Tweet
Hello All,
I will be evaluating changes in various gait parameters using a GAITRite system as well changes in nerve conduction velocity within cancer patients undergoing chemotherapy and experiencing peripheral neuropathy.
I was wondering if any has worked with this patient population before ( or individuals with diabetic peripheral neuropathy) and, due to the fragile nature of this patient population, could offer some advice with regards to the data collection process and methodology? Did anyone have any unforeseen issues? Particularly with the Nerve Conduction velocities, what may be the best way to evaluate?
Your expertise is much appreciated,
Tim
I will be evaluating changes in various gait parameters using a GAITRite system as well changes in nerve conduction velocity within cancer patients undergoing chemotherapy and experiencing peripheral neuropathy.
I was wondering if any has worked with this patient population before ( or individuals with diabetic peripheral neuropathy) and, due to the fragile nature of this patient population, could offer some advice with regards to the data collection process and methodology? Did anyone have any unforeseen issues? Particularly with the Nerve Conduction velocities, what may be the best way to evaluate?
Your expertise is much appreciated,
Tim